The etiology of treatment-related lymphopenia in patients with malignant gliomas: Modeling radiation dose to circulating lymphocytes explains clinical observations and suggests methods of modifying the impact of radiation on immune cells

Cancer Investigation

Volumn 31, Issue 2, 2013, Pages 140-144

  Yovino, Susannah ^a   Kleinberg, Lawrence ^a   Grossman, Stuart A ^a   Narayanan, Manisha ^b   Ford, Eric ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Brain Radiation; Glioblastoma; High Grade Gliomas; Lymphocytes; Lymphopenia; Normal Tissue Toxicity; Survival

Indexed keywords

GLUCOCORTICOID; TEMOZOLOMIDE;

ARTICLE; BRAIN TUMOR; CANCER RADIOTHERAPY; CANCER SURVIVAL; CIRCULATING TUMOR CELL; CLINICAL FEATURE; CONTROLLED STUDY; DATA ANALYSIS SOFTWARE; GLIOBLASTOMA; HUMAN; IMMUNOCOMPETENT CELL; LYMPHOCYTE; LYMPHOCYTOPENIA; PRIORITY JOURNAL; RADIATION DOSE; RADIATION FIELD; STANDARD; TUMOR VOLUME;

BRAIN NEOPLASMS; GLIOMA; HUMANS; LYMPHOCYTES; LYMPHOPENIA; MODELS, BIOLOGICAL; NEOPLASMS, RADIATION-INDUCED; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, CONFORMAL; SOFTWARE;

EID: 84873129162     PISSN: 07357907     EISSN: 15324192     Source Type: Journal    
DOI: 10.3109/07357907.2012.762780     Document Type: Article

References (17)

1. Mahindra AK, Grossman SA. Pneumocystis carinii pneumonia in HIV negative patients with primary brain tumors. J Neurooncol 2003;63(3):263-270. (Pubitemid 36874010)
2. Meije Y, Lizasoain M, Garcia-Reyne A, et al. Emergence of cytomegalovirus disease in patients receiving temozolomide: report of two cases and literature review. Clin Infect Dis 2010;50(12):e73-e76. doi: 10.1086/653011.
3. Balmanoukian A, Ye X, Herman J, Laheru D, Grossman S. Effect of treatment-related lymphopenia on survival in newly diagnosed patients with adenocarcinoma of the pancreas. Clin Invest 2012;In press.
4. Grossman SA, Ye X, Lesser G, et al. Immunosuppression in patients with high-grade gliomas treated with radiation and temozolomide. Clin Cancer Res 2011;17(16):5473-5480. doi: 10.1158/1078-0432.CCR-11-0774; 10.1158/1078-0432. CCR- 11-0774.
5. Hughes MA, Parisi M, Grossman S, Kleinberg L. Primary brain tumors treated with steroids and radiotherapy: Low CD4 counts and risk of infection. Int J Radiat Oncol Biol Phys 2005;62(5):1423-1426. doi: 10.1016/j.ijrobp.2004. 12.085. (Pubitemid 40982064)
6. Shohan J. Some theoretical considerations on the present status of roentgen therapy. N Engl J Med 1916;175:321-327.
7. MacLennan IC, Kay HE. Analysis of treatment in childhood leukemia. IV. The critical association between dose fractionation and immunosuppression induced by cranial irradiation. Cancer 1978;41(1):108-111. (Pubitemid 8286417)
8. Weeke E. The development of lymphopenia in uremic patients undergoing extracorporeal irradiation of the blood with portable beta units. Radiat Res 1973;56(3):554-559.
9. Ganong W, (ed). Review ofMedical Physiology, 21st edition,New York, NY: Lange Medical Books, McGraw-Hill, 2003.
10. Nakamura N, Kusunoki Y, Akiyama M. Radiosensitivity of CD4 or CD8 positive human T-lymphocytes by an in vitro colony formation assay. Radiat Res 1990;123(2):224-227. (Pubitemid 20262304)
11. Schrek R. Qualitiative and quantitative reactions of lymphocytes to x-rays. Ann New York Acad Sci 1961;95:839-48.
12. United Nations Scientific Committee on the Effects of Atomic Radiation (UNSCEAR). Effects of Ionizing Radiation, Annex D: Effects of Ionizing Radiation on the Immune System. New York: United Nations Publications, 2006.
13. Belka C, Ottinger H, Kreuzfelder E, et al. Impact of localized radiotherapy on blood immune cells counts and function in humans. Radiother Oncol 1999;50(2):199-204. (Pubitemid 29155546)
14. Wild AT, Yovino S, Smith JA, et al. Degree of chemoradiationassociated lymphopenia is related to radiation field size in patients with locally advanced pancreatic cancer. Annu. Meeting Am Radium Soc 2012.
15. Kantoff PW, Higano CS, Shore ND, et al. Sipuleucel-T immunotherapy for castration-resistant prostate cancer. N Engl J Med 2010;363(5):411-422. doi: 10.1056/NEJMoa1001294.
16. Ku GY, Yuan J, Page DB, et al. Single-institution experience with ipilimumab in advanced melanoma patients in the compassionate use setting: lymphocyte count after 2 doses correlates with survival. Cancer 2010;116(7):1767-1775. doi: 10.1002/cncr.24951.
17. Jones B. Modelling carcinogenesis after radiotherapy using poisson statistics: implications for IMRT, protons and ions. J Radiol Prot 2009;29(2A):A143-A157. doi: 10.1088/0952- 4746/29/2A/S10.